These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 19037815)

  • 21. Influence of hepatitis C and hepatitis G virus co-infection on viral and cellular dynamics in patients infected with human immunodeficiency virus following interruption of highly active anti-retroviral therapy.
    Soriano-Sarabia N; Abad MA; Vallejo A; Gutiérrez S; Leal M
    Clin Microbiol Infect; 2006 Mar; 12(3):290-3. PubMed ID: 16451419
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Consensus document of Gesida and Spanish Secretariat for the National Plan on AIDS (SPNS) regarding combined antiretroviral treatment in adults infected by the human immunodeficiency virus (January 2012)].
    Panel de expertos de Gesida y Plan Nacional sobre el Sida
    Enferm Infecc Microbiol Clin; 2012 Jun; 30(6):e1-89. PubMed ID: 22633764
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical features of acute human immunodeficiency virus infection in Taiwan: A multicenter study.
    Lin TY; Yang CJ; Liu CE; Tang HJ; Chen TC; Chen GJ; Hung TC; Lin KY; Cheng CY; Lee YC; Lin SP; Tsai MS; Lee YL; Cheng SH; Hung CC; Wang NC;
    J Microbiol Immunol Infect; 2019 Oct; 52(5):700-709. PubMed ID: 29555411
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Predictors of virological outcome and safety in primary HIV type 1-infected patients initiating quadruple antiretroviral therapy: QUEST GW PROB3005.
    Hoen B; Cooper DA; Lampe FC; Perrin L; Clumeck N; Phillips AN; Goh LE; Lindback S; Sereni D; Gazzard B; Montaner J; Stellbrink HJ; Lazzarin A; Ponscarme D; Staszewski S; Mathiesen L; Smith D; Finlayson R; Weber R; Wegmann L; Janossy G; Kinloch-de Loes S;
    Clin Infect Dis; 2007 Aug; 45(3):381-90. PubMed ID: 17599319
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Structured treatment interruptions (STI) in chronic unsuppressed HIV infection in adults.
    Pai NP; Lawrence J; Reingold AL; Tulsky JP
    Cochrane Database Syst Rev; 2006 Jul; 2006(3):CD006148. PubMed ID: 16856117
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High-throughput sequencing for the aetiologic identification of viral encephalitis, meningoencephalitis, and meningitis. A narrative review and clinical appraisal.
    Zanella MC; Lenggenhager L; Schrenzel J; Cordey S; Kaiser L
    Clin Microbiol Infect; 2019 Apr; 25(4):422-430. PubMed ID: 30641229
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Spanish GESIDA/Nacional AIDS Plan Recommendations for antiretroviral therapy in HIV-infected Adults (October 2004)].
    Iribarren JA; Labarga P; Rubio R; Berenguer J; Miró JM; Antela A; González J; Moreno S; Arrizabalaga J; Chamorro L; Clotet B; Gatell JM; López-Aldeguer J; Martínez E; Polo R; Tuset M; Viciana P; Santamaría JM; Kindelán JM; Ribera E; Segura F; ;
    Enferm Infecc Microbiol Clin; 2004 Dec; 22(10):564-642. PubMed ID: 15596051
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interruption of combination antiretroviral therapy and risk of clinical disease progression to AIDS or death.
    Holkmann Olsen C; Mocroft A; Kirk O; Vella S; Blaxhult A; Clumeck N; Fisher M; Katlama C; Phillips AN; Lundgren JD;
    HIV Med; 2007 Mar; 8(2):96-104. PubMed ID: 17352766
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of active treatment discontinuation in patients with a CD4+ T-cell nadir greater than 350 cells/mm3: 48-week Treatment Interruption in Early Starters Netherlands Study (TRIESTAN).
    Pogány K; van Valkengoed IG; Prins JM; Nieuwkerk PT; van der Ende I; Kauffmann RH; Kroon FP; Verbon A; Nievaard MF; Lange JM; Brinkman K
    J Acquir Immune Defic Syndr; 2007 Apr; 44(4):395-400. PubMed ID: 17195761
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [National consensus document by GESIDA/National Aids Plan on antiretroviral treatment in adults infected by the human immunodeficiency virus (January 2011 update)].
    Panel de expertos de GESIDA y Plan Nacional sobre el Sida
    Enferm Infecc Microbiol Clin; 2011 Mar; 29(3):209.e1-103. PubMed ID: 21388714
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Changes in HIV RNA and CD4 cell count after acute HCV infection in chronically HIV-infected individuals.
    Gras L; de Wolf F; Smit C; Prins M; van der Meer JT; Vanhommerig JW; Zwinderman AH; Schinkel J; Geskus RB;
    J Acquir Immune Defic Syndr; 2015 Apr; 68(5):536-42. PubMed ID: 25559595
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of Cryptococcus antigen in human immunodeficiency virus-positive Turkish patients by using the Dynamiker
    Karaman E; Ilkit M; Kuşçu F
    Mycoses; 2019 Oct; 62(10):961-968. PubMed ID: 31344286
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Recommendations from the GESIDA/Spanish AIDS Plan regarding antiretroviral treatment in adults with human immunodeficiency virus infection (update February 2009)].
    Panel de expertos de Gesida y Plan Nacional sobre el Sida
    Enferm Infecc Microbiol Clin; 2009 Apr; 27(4):222-35. PubMed ID: 19246124
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Central Nervous System Safety During Brief Analytic Treatment Interruption of Antiretroviral Therapy Within 4 Human Immunodeficiency Virus Remission Trials: An Observational Study in Acutely Treated People Living With Human Immunodeficiency Virus.
    Hellmuth J; Muccini C; Colby DJ; Kroon E; de Souza M; Crowell TA; Chan P; Sacdalan C; Intasan J; Benjapornpong K; Tipsuk S; Puttamaswin S; Chomchey N; Valcour V; Sarnecki M; Tomaka F; Krebs SJ; Slike BM; Jagodzinski LL; Dumrongpisutikul N; Sailasuta N; Samboju V; Michael NL; Robb ML; Vasan S; Ananworanich J; Phanuphak P; Phanuphak N; Paul R; Spudich S
    Clin Infect Dis; 2021 Oct; 73(7):e1885-e1892. PubMed ID: 32916708
    [TBL] [Abstract][Full Text] [Related]  

  • 35. HIV-1 viral rebound dynamics after a single treatment interruption depends on time of initiation of highly active antiretroviral therapy.
    Steingrover R; Pogány K; Fernandez Garcia E; Jurriaans S; Brinkman K; Schuitemaker H; Miedema F; Lange JM; Prins JM
    AIDS; 2008 Aug; 22(13):1583-8. PubMed ID: 18670217
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Interruption of antiretroviral therapy in chronically HIV-infected patients].
    Amador C; Pasquau F; Ena J; Benito C; Ruiz de Apodaca RF
    Med Clin (Barc); 2005 Jun; 125(2):41-5. PubMed ID: 15970181
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Complementary findings in clinical and epidemiologic features of mumps and mumps meningoencephalitis in children without mumps vaccination.
    Kanra G; Isik P; Kara A; Cengiz AB; Seçmeer G; Ceyhan M
    Pediatr Int; 2004 Dec; 46(6):663-8. PubMed ID: 15660864
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Glycaemic profile changes by highly active antiretroviral therapy in human immunodeficiency virus-infected patients.
    Duro M; Rebelo I; Barreira S; Sarmento-Castro R; Medeiros R; Almeida C
    Int J STD AIDS; 2015 Oct; 26(11):796-802. PubMed ID: 25281540
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Recommendations from the GESIDA/Spanish AIDS Plan regarding antiretroviral treatment in adults with human immunodeficiency virus infection (update January 2007)].
    ;
    Enferm Infecc Microbiol Clin; 2007 Jan; 25(1):32-53. PubMed ID: 17261244
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cortical sources of resting-state EEG rhythms in "experienced" HIV subjects under antiretroviral therapy.
    Babiloni C; Buffo P; Vecchio F; Onorati P; Muratori C; Ferracuti S; Roma P; Battuello M; Donato N; Noce G; Di Campli F; Gianserra L; Teti E; Aceti A; Soricelli A; Viscione M; Andreoni M; Rossini PM; Pennica A
    Clin Neurophysiol; 2014 Sep; 125(9):1792-802. PubMed ID: 24631008
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.